Consensus Molecure S.A.

Equities

MOC

PLONCTH00011

Market Closed - Warsaw S.E. Other stock markets 17:03:11 28/06/2024 BST			5-day change	1st Jan Change
13.72 ^PLN	-0.58%		-3.38%	-29.64%

05-21	Molecure S.A. Receives Approval to Initiate A Phase II Clinical Trial for OATD-01 for the Treatment of Pulmonary Sarcoidosis in Selected Countries of the European Union and Norway	CI
05-17	Molecure S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Molecure S.A.

Price target over the last 5 years

History of analyst recommendation changes

c2a28527d37c82c1e4c.sseC5xmkqsFToUR0cwEFHGquuhJaFcYTzrdsLEtUmbU.6oO13ljpzZd-kBFFRW9aehCY2VwTRY1XvuU_YgIsrcfXgrKRavbuiwDGNw~00c98831a652123fd6a3ee8f3c4e0559